Marco Lorenzoni

5PUBLICATIONS
104CO-AUTHORS
Molecular targetsCancer geneticsMedical infection agents (incl. prions)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 05, 2026
Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Arianna Brevi, Marco Lorenzoni, Sara Caputo

|Dec 04, 2025
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Urvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garcés

|Nov 25, 2025
Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma.

Laura Lucia Cogrossi, Anna Policastro, Paola Zordan

|Dec 05, 2024
Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.

Dario De Felice, Alessandro Alaimo, Davide Bressan

|Mar 07, 2022
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence.

Francesco Cambuli, Veronica Foletto, Alessandro Alaimo

Pageof 1

Frequent Collaborators

3 joint publications

Matteo Bellone

3 joint publications

Matteo Grioni

2 joint publications

Veronica Foletto

2 joint publications

Alessandro Alaimo